Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-26-000462
Filing Date
2026-04-23
Accepted
2026-04-23 18:50:38
Documents
1
Period of Report
2026-04-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8750
  Complete submission text file 0000947871-26-000462.txt   10268
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Bonita David P (Reporting) CIK: 0001572451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 26890063

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)